FNArena Windows
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
| ASX CODE | LAST PRICE | % MOVE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET | UPSIDE/DOWNSIDE |
|---|---|---|---|---|---|---|---|
| 360 | $43.73 |
|
$45.42 | $14.93 | 61.1 |
$47.625 |
|
| 3DP | $0.05 |
|
$0.11 | $0.04 |
|
||
| AIM | $0.54 | 0.00% | $0.95 | $0.38 |
$0.80 |
|
|
| ALC | $0.10 | 0.00% | $0.14 | $0.05 | 125.0 |
$0.13 |
|
| AMX | $0.21 | 0.00% | $0.36 | $0.17 |
|
||
| APX | $0.85 |
|
$3.11 | $0.77 |
$1.65 |
|
|
| AR9 | $0.19 |
|
$0.28 | $0.05 |
|
||
| ATA | $0.81 |
|
$1.28 | $0.70 | 15.3 |
$1.05 |
|
| AV1 | $0.15 | 0.00% | $0.17 | $0.06 |
$0.20 |
|
|
| BMT | $0.27 |
|
$0.38 | $0.18 |
$0.70 |
|
|
| COS | $0.65 |
|
$1.09 | $0.46 | 15.5 |
$0.925 |
|
| DGT | $2.79 |
|
$4.92 | $2.28 | 21.2 |
$4.25 |
|
| DOC | $0.13 | 0.00% | $0.16 | $0.06 |
$0.12 |
|
|
| DTL | $7.90 |
|
$8.92 | $6.12 | 26.7 |
$8.375 |
|
| DUB | $0.02 | 0.00% | $0.06 | $0.01 |
|
||
| DUG | $1.33 |
|
$3.29 | $0.85 |
$2.59 |
|
|
| DXN | $0.06 | 0.00% | $0.11 | $0.03 |
|
||
| ERD | $2.19 |
|
$2.30 | $0.73 | 77.3 |
$1.80 |
|
| EVS | $0.09 | 0.00% | $0.09 | $0.04 |
|
||
| FCL | $2.95 |
|
$3.17 | $1.22 |
$2.82 |
|
|
| FCT | $0.01 | 0.00% | $0.03 | $0.01 |
|
||
| FLN | $0.29 | 0.00% | $0.33 | $0.15 |
|
||
| GTK | $9.15 |
|
$13.13 | $8.51 | 69.7 |
$12.833 |
|
| HSN | $5.60 |
|
$6.20 | $4.15 | 24.6 |
$6.95 |
|
| IFT | $11.00 |
|
$12.05 | $8.44 | 50.8 |
|
|
| IRI | $0.46 |
|
$0.79 | $0.35 | 5.8 |
$0.70 |
|
| KYP | $0.28 | 0.00% | $0.30 | $0.10 | 70.0 |
$0.32 |
|
| MAQ | $68.13 |
|
$91.39 | $52.66 | 48.2 |
$102.00 |
|
| MP1 | $14.80 |
|
$15.55 | $6.61 | 143.0 |
$13.208 |
|
| NXL | $2.22 |
|
$7.85 | $1.79 | 82.5 |
$5.70 |
|
| NXT | $14.20 |
|
$18.21 | $9.40 | -162.3 |
$19.592 |
|
| OCL | $19.00 |
|
$20.16 | $12.10 | 52.2 |
$17.333 |
|
| QOR | $0.65 |
|
$0.71 | $0.31 |
$0.54 |
|
|
| RCL | $0.10 | 0.00% | $0.15 | $0.07 |
|
||
| RDY | $2.61 |
|
$3.35 | $2.09 | 58.7 |
$3.713 |
|
| RKN | $0.61 |
|
$0.67 | $0.45 |
|
||
| SDR | $5.26 | 0.00% | $6.91 | $3.40 | -103.6 |
$6.308 |
|
| SKO | $2.31 |
|
$3.60 | $2.30 |
$4.66 |
|
|
| STG | $0.40 |
|
$0.66 | $0.35 |
$0.52 |
|
|
| TNE | $38.76 |
|
$42.88 | $22.31 | 92.3 |
$37.582 |
|
| UBN | $0.78 | 0.00% | $0.90 | $0.36 |
|
||
| VGL | $2.86 | 0.00% | $3.70 | $2.28 |
$4.10 |
|
|
| WTC | $113.16 |
|
$141.61 | $67.80 | 98.7 |
$135.067 |
|
| XF1 | $0.20 | 0.00% | $0.22 | $0.10 |
|
||
| XPN | $0.01 | 0.00% | $0.03 | $0.01 |
|
||
| XRO | $170.30 |
|
$196.52 | $134.00 | 87.5 |
$213.167 |
|
| YOJ | $0.42 | 0.00% | $0.54 | $0.05 |
|
-1.86% 
8.9% Previous Stories
The GenAI Arms Race Is Just Getting Started
Mar 19 2025
Selling in public markets and tumbling tech equity valuations are not telling the full GenAI story, as private markets and China power on
Pro Medicus’ Valuation Predicament
Feb 19 2025
Pro Medicus continues to win contacts at an accelerating pace, leaving brokers to raise targets on a promising outlook and simultaneously question a demanding valuation
DeepSeek Fuels AI Technology Advances
Feb 06 2025
The pace of artificial intelligence innovation was reinforced with DeepSeek and it’s all systems go with software and hardware working in combination
DeepSeek & More AI Excitement For 2025
Jan 28 2025
The rapid pace of AI evolution continues, what’s new, and which sectors/stocks are in focus
Xero: The Pause That Refreshes
Jan 23 2025
The Chartist suggests Xero shares are consolidating before resuming their uptrend
Pro Medicus, A Global Software Super Star
Dec 19 2024
Pro Medicus’ growth story is far from over. How should investors deal with the valuation challenge of one of Australia’s premium growth companies?
Higher Margins Underpin Gentrack’s Ambitions
Nov 28 2024
The positive trend for Gentrack Group continues with FY24 results triggering higher margin forecasts from analysts
Targets Jump For Embattled WiseTech
Nov 28 2024
Unwanted media attention has led to an earnings downgrade for WiseTech Global, but analysts have taken the opportunity to reassess valuations and significantly lift target prices
Nuix Rises From The Ashes
Nov 08 2024
After a post IPO car crash for investors, Nuix has turned the corner as it hits its AI straps and draws comparisons to US tech stock Palantir
WiseTech In Global Supply Chain Sweet Spot
Oct 10 2024
New research highlights WiseTech Global’s software will be in demand to help supply chains recover and meet new e-commerce requirements